(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

US ONCOLOGY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

US ONCOLOGY

ST13

US500000075698864

Class

35

Filing

75698864

Registration

2336900

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

07/14/2021

Trademark type

Word

Nice classes

35

Filing date

05/06/1999

Registration date

03/28/2000

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/14/2021

Last transaction

07/14/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

06/15/1999

First use in commerce

06/15/1999

Drawing code

1

Owner type

03

Owner location

The Woodlands, TX, US

Examiner

VANSTON, KATHY

Law office

L30

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

US ONCOLOGY, INC.
US ONCOLOGY, INC.
AMERICAN ONCOLOGY RESOURCES, INC.

Representatives

Auma N. Reggy McKesson Corporation

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

business management services for groups that provide medical services

Publications

History of USPTO decisions and trademark events.

36 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/14/2021

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

07/14/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/14/2021

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

06/28/2021

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

12/26/2020

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

12/08/2020

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

06/09/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/08/2020

E89R

TEAS SECTION 8 & 9 RECEIVED

03/25/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

03/28/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/28/2013

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/14/2009

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/14/2009

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/17/2009

E89R

TEAS SECTION 8 & 9 RECEIVED

09/14/2009

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/14/2009

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/14/2009

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/09/2009

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/11/2006

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/11/2006

CFIT

CASE FILE IN TICRS

04/21/2006

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

03/02/2006

PLGL

ASSIGNED TO PARALEGAL

02/01/2006

8.AF

REGISTERED - SEC. 8 (6-YR) FILED

12/29/2005

ES8R

TEAS SECTION 8 RECEIVED

12/29/2005

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/25/2004

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/24/2004

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

03/28/2000

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

02/03/2000

IUAA

USE AMENDMENT ACCEPTED

02/03/2000

CNEA

EXAMINER'S AMENDMENT MAILED

01/24/2000

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

11/24/1999

IUAF

USE AMENDMENT FILED

11/05/1999

CNRT

NON-FINAL ACTION MAILED

09/30/1999

DOCK

ASSIGNED TO EXAMINER

09/28/1999

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/13/1999

Continuous trademark protection

Get notified about every new filing that threatens US ONCOLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.